Our group is developing novel bioanalytical technologies, like microfluidic instrumentation and nanoscale biosensors, to allow us to listen in on chemical communications that occur between the brain and body (i.e. neuroendocrine processes). Faster, more specific, and higher sensitivity measurements will elucidate the roles of peptide signaling in behavior and may shed new light on mechanisms of neurodevelopmental disorders like autism.